Methotrexate NDC 70771-1058

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1058Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1058Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70771-1058-0	70771105800	1000 TABLET in 1 BOTTLE (70771-1058-0)Marketed from Feb 9, 2017
70771-1058-1	70771105801	100 TABLET in 1 BOTTLE (70771-1058-1)Marketed from Feb 9, 2017
70771-1058-3	70771105803	36 TABLET in 1 BOTTLE (70771-1058-3)Marketed from Feb 9, 2017
70771-1058-5	70771105805	500 TABLET in 1 BOTTLE (70771-1058-5)Marketed from Feb 9, 2017
70771-1058-7	70771105807	100 BLISTER PACK in 1 CARTON (70771-1058-7) / 1 TABLET in 1 BLISTER PACK (70771-1058-2)Marketed from Feb 9, 2017
70771-1058-9	70771105809	90 TABLET in 1 BOTTLE (70771-1058-9)Marketed from Feb 9, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methotrexate
Generic name (nonproprietary): methotrexate
Active ingredients: Methotrexate — 2.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Lifesciences Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207812
Marketing start: Feb 9, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Folic Acid Metabolism Inhibitors (Mechanism)
Identifiers: Product ID 70771-1058_ae399908-cfb6-44dc-83da-8981f5dabbb8SPL ID ae399908-cfb6-44dc-83da-8981f5dabbb8SPL set ID 59ea7b32-2b6d-4197-92c3-015936f04ebeRxCUI 105585UNII YL5FZ2Y5U1
Pharmacologic class: Folate Analog Metabolic Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771105800 followed by a unit qualifier and the quantity

Package 70771-1058-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2024.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207812

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207812
Product	Strength	Form · route	Labeler	Product NDC
Methotrexate	Methotrexate 2.5 mg/1	TabletOral	AvPAK	50268-554
Methotrexate	Methotrexate 2.5 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-775
Methotrexate	Methotrexate 2.5 mg/1	TabletOral	Major Pharmaceuticals	0904-7141